US clinical trial result is great, but no doctor should change course of treatment right away
Everyone is, not surprisingly, excited about the “astonishing” results of a small clinical trial in which all signs of colorectal cancer vanished from the participants. Dr Kumar Prabhash, head of medical oncology at Tata Memorial Hospital, Mumbai, who perhaps has the widest experience in India of using the class of drugs used in the above trial, sounds a note of caution, asking for the “striking” results to be replicated and long-term results analysed before we celebrate. A sure-shot cure for cancer hasn’t yet been found, he tells Malathy Iyer:
Q: Tell us about Dostarlimab, which is being hailed as the promising breakthrough for the treatment of colorectal cancer.
Q: Tell us about Dostarlimab, which is being hailed as the promising breakthrough for the treatment of colorectal cancer.